FDA Import Refusal 799-8090829-5/11/2 — Novartis Pharmaceuticals
The FDA refused shipment 799-8090829-5/11/2 from Novartis Pharmaceuticals (Australia) on Aug 3, 2020. The refused product falls under Drugs and Biologics — DICLOFENAC POTASSIUM (ANTI-INFLAMMATORY). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Aug 3, 2020
- Country
- Australia
- Product Category
- Drugs and Biologics
- Product Code
- 62GCB90 DICLOFENAC POTASSIUM (ANTI-INFLAMMATORY)
- Charges
- 75